Bahrain vs Fiji: The number of people with susceptibility test result for rifampicin
Bahrain
112
in 2021
Fiji
127
in 2021
Bahrain rank
107th
Fiji rank
105th
The number of people with susceptibility test result for rifampicin over time
- Bahrain
- Fiji
How they compare
Fiji currently reports 127 against 112 in Bahrain, a difference of 15.
That makes Fiji's figure about 1.1 times Bahrain's.
Across all 5 years both countries report, Fiji has been ahead every year.
Bahrain ranks 107th and Fiji ranks 105th of 155 countries.
Fiji has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahrain | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84 | 139 | 55 | Fiji |
| 2020s | 97 | 123.5 | 26.5 | Fiji |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bahrain or Fiji?
- Fiji, at 127 against 112 in Bahrain as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bahrain and Fiji?
- 15, with Fiji ahead.
- How many years of comparable data are there for Bahrain and Fiji?
- 5 years are reported by both, from 2017 to 2021.
- How do Bahrain and Fiji rank globally for the number of people with susceptibility test result for rifampicin?
- Bahrain ranks 107th and Fiji ranks 105th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.